Products & ServicesEvent: August 31, 2026
Gossamer Bio built a system to capture and act on off-priority signals from field medical.
Published
Signal category
Products & Services
Quote
“We built a system to make sure we listen.”
— Mathijs Kruk|Gossamer Bio team
Company
Gossamer Bio
Vision * Connection * Innovation
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 130 employees
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.
Founded 2017